Vladimir Zarnitsyn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vladimir zarnitsyn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vladimir Zarnitsyn Today - Breaking & Trending Today

RADCOM (NASDAQ:RDCM) Earns Buy Rating from Analysts at StockNews.com

Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Rating) has received a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price target […] ....

United States , Mark Prausnitz , Danielh White , Vladimir Zarnitsyn , Samir Kumar Patel , Clearside Biomedical Inc , Renaissance Technologies , Lincoln National Corp , Clearside Biomedical Company Profile , Needham Company , Janney Montgomery Scott , America Corp , Clearside Biomedical , Get Rating , Montgomery Scott , Integrin Inhibitor , Clearside Biomedical Daily , Nasdaq Clsd ,

Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Update

Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Rating) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 568,400 shares, an increase of 102.8% from the April 30th total of 280,300 shares. Approximately 1.1% of the company’s shares are short sold. Based on an average […] ....

Mark Prausnitz , Samir Kumar Patel , Vladimir Zarnitsyn , Danielh White , Water Island Capital , Ameritas Advisory Services , Needham Company , Janney Montgomery Scott , Stratos Wealth Partners , Clearside Biomedical Inc , Financial Consultants Inc , Clearside Biomedical , Get Rating , Island Capital , Montgomery Scott , Wealth Partners , Advisory Services , Integrin Inhibitor , Clearside Biomedical Daily , Nasdaq Clsd ,

Clearside Biomedical (NASDAQ:CLSD) Rating Increased to Hold at StockNews.com

StockNews.com upgraded shares of Clearside Biomedical (NASDAQ:CLSD – Get Rating) from a sell rating to a hold rating in a research report released on Wednesday. Several other research firms have also recently weighed in on CLSD. 500.com reissued a reiterates rating on shares of Clearside Biomedical in a research note on Friday, April 28th. HC […] ....

Banque Cantonale Vaudoise , Samir Kumar Patel , Mark Prausnitz , Vladimir Zarnitsyn , Danielh White , Needham Company , Clearside Biomedical Inc , Stratos Wealth Partners , Jpmorgan Chase Co , Mackenzie Financial Corp , Balyasny Asset Management , Clearside Biomedical , Get Rating , Moderate Buy , Asset Management , Wealth Partners , Financial Corp , Integrin Inhibitor , Clearside Biomedical Daily , Nasdaq Clsd , Stocknews Com ,

Clearside Biomedical (NASDAQ:CLSD) Upgraded to "Hold" by StockNews.com

StockNews.com upgraded shares of Clearside Biomedical (NASDAQ:CLSD – Get Rating) from a sell rating to a hold rating in a research note released on Wednesday. Other research analysts also recently issued reports about the company. 500.com reiterated a reiterates rating on shares of Clearside Biomedical in a research report on Friday, April 28th. JMP Securities […] ....

Samir Kumar Patel , Danielh White , Vladimir Zarnitsyn , Mark Prausnitz , Needham Company , Mackenzie Financial Corp , Clearside Biomedical Company Profile , Topco Ltd , Renaissance Technologies , Clearside Biomedical Inc , Synovus Financial Corp , Clearside Biomedical , Get Rating , Moderate Buy , Biomedical Stock Down , Financial Corp , State Street Corp , Street Corp , Integrin Inhibitor , Clearside Biomedical Daily , Nasdaq Clsd , Stocknews Com ,

StockNews.com Downgrades Clearside Biomedical (NASDAQ:CLSD) to Sell

StockNews.com cut shares of Clearside Biomedical (NASDAQ:CLSD – Get Rating) from a hold rating to a sell rating in a research report released on Tuesday morning. CLSD has been the subject of several other research reports. Needham & Company LLC restated a buy rating and set a $4.00 price target on shares of Clearside Biomedical […] ....

United States , Danielh White , Mark Prausnitz , Samir Kumar Patel , Vladimir Zarnitsyn , Clearside Biomedical Inc , Renaissance Technologies , Janney Montgomery Scott , Needham Company , Clearside Biomedical Company Profile , America Corp , Clearside Biomedical , Get Rating , Moderate Buy , Street Corp , Integrin Inhibitor , Clearside Biomedical Daily , Nasdaq Clsd , Stocknews Com ,